A new class of nifuroxazide analogues: Synthesis of 5-nitrothiophene derivatives with antimicrobial activity against multidrug-resistant Staphylococcus aureus

Bioorganic and Medicinal Chemistry

Volumn 15, Issue 12, 2007, Pages 4229-4236

  Masunari, Andrea ^a   Tavares, Leoberto Costa ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Analogue preparation; Antimicrobials; MIC; MRSA; Nifuroxazide

Indexed keywords

3,4 DICHLOROBENZOIC ACID [(5 NITROTHIOPHEN 2 YL)METHYLENE]HYDRAZIDE; 4 ACETYLBENZOIC ACID [(5 NITROTHIOPHEN 2 YL)METHYLENE]HYDRAZIDE; 4 BROMOBENZOIC ACID [(5 NITROTHIOPHEN 2 YL)METHYLENE]HYDRAZIDE; 4 BUTOXYBENZOIC ACID [(5 NITROTHIOPHEN 2 YL)METHYLENE]HYDRAZIDE; 4 BUTYLAMINE BENZOIC ACID [(5 NITROTHIOPHEN 2 YL)METHYLENE]HYDRAZIDE; 4 BUTYLBENZOIC ACID [(5 NITROTHIOPHEN 2 YL)METHYLENE]HYDRAZIDE; 4 CHLOROBENZOIC ACID [(5 NITROTHIOPHEN 2 YL)METHYLENE]HYDRAZIDE; 4 ETHYLBENZOIC ACID [(5 NITROTHIOPHEN 2 YL)METHYLENE]HYDRAZIDE; 4 IODOBENZOIC ACID [(5 NITROTHIOPHEN 2 YL)METHYLENE]HYDRAZIDE; 4 ISOPROPYLBENZOIC ACID [(5 NITROTHIOPHEN 2 YL)METHYLENE]HYDRAZIDE; 4 PROPOXYBENZOIC ACID [(5 NITROTHIOPHEN 2 YL)METHYLENE]HYDRAZIDE; 4 PROPYLBENZOIC ACID [(5 NITROTHIOPHEN 2 YL)METHYLENE]HYDRAZIDE; 4 VINYLBENZOIC ACID [(5 NITROTHIOPHEN 2 YL)METHYLENE]HYDRAZINE; BENZOIC ACID [(5 NITROTHIOPHEN 2 YL)METHYLENE]HYDRAZIDE; HYDRAZIDE DERIVATIVE; NIFUROXAZIDE; THIOPHENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; DILUTION; DRUG ACTIVITY; DRUG SYNTHESIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; SUBSTITUTION REACTION;

ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, MULTIPLE; HYDROXYBENZOIC ACIDS; MAGNETIC RESONANCE SPECTROSCOPY; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; NITROFURANS; SPECTROPHOTOMETRY, INFRARED; STAPHYLOCOCCUS AUREUS;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 34247581707     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2007.03.068     Document Type: Article

References (24)

1. Chierakul W., Rajanuwong A., Wuthiekanun V., Teerawattanasook N., Gasiprong M., Simpson A., Chaowagul W., and White N.J. Trans. Royal Soc. Trop. Med. Hig 98 (2004) 678
2. Onorato M. Infect. Contr. Hosp. Epidem 20 (1999) 26
3. Burd M., Humphres H., Glyn G., Mitchell E., McDonald P., Johnson H., McDonnell B., Doyle D., and Rossney A. J. Hosp. Infect. 53 (2003) 297
4. Desai D., Desai N., Nightingale P., Elliot T., and Neuberger J. Liver Transpl. 9 (2003) 754
5. Fernandes P.B., Menzel R., Hardy D.J., Tse-Dinh Y., Warren A., and Elsemore D.A. Med. Res. Rev. 19 (1999) 559
6. Brenwald N.P., and Fraise A.P. J. Hosp. Infect. 55 (2003) 141
7. Fuchs P.C., Koop J., Hafner H., Kleiner U., and Pallua N. Burns 28 (2002) 575
8. Maudsley J., Stone S.P., Kibbler C.C., Iliffe S.R., Conaty S.J., Cookson B.D., Duckworth G.J., Johnson A., and Wallace P.G. J. Hosp. Infect. 57 (2004) 258
9. Trzcinnski K., Cooper B.S., Hrynievicz W., and Dowson C.G. J. Antimicrob. Chemother. 45 (2000) 763
10. In: Barreiro E.J., and Fraga C.A.M. (Eds). Qui{dotless}́mica Medicinal (2001), Artmed Editora, Porto Alegre 83
11. Dayan J., Deguingand C., and Truzman C. Mutat. Res. 157 (1985) 1
12. Petri Jr. W.A. Antimicrobial agents. In: Hardman J.G., Limbird L.E., and Gilman A.G. (Eds). Goodman & Gilman's: The pharmacological Basis of Therapeutics. 10th ed. (2001), McGraw-Hill, New York 1171
13. Tavares L.C., Chisté J.J., Santos M.G.B., and Penna T.C.V. Boll. Chim. Farm 138 (1999) 432
14. Tavares L.C., Penna T.C.V., and Amaral A.T. Boll. Quim. Farm. 136 (1997) 244
15. In: Hansch C., and Leo A. (Eds). Exploring QSAR: Fundamentals and Applications in Chemistry and Biology (1995), American Chemical Society, Washington p. 557
16. In: Kubinyi H. (Ed). QSAR: Hansch Analysis and Related Approaches (1993), VCH, New York p. 240
17. Topliss J.G. J. Med. Chem 15 (1972) 1006
18. National Committee for Clinical Laboratory Standards, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 6nd ed., 2003, M7-A6 (ISBN 1-56238-486-4).
19. Oliveira G.A., Dell'Aquila A.M., Masiero R.L., Levy C.E., Gomes M.S., Cui L., Hiramatsu K., and Mamizuka E.M. Infect. Contr. Hosp. Epidem. 22 (2001) 443
20. Masunari, A.; Rezende, P.; Tavares, L.C. Abstracts of Papers, 15th European Symposium on Quantitative Structure-Activity Relationships & Molecular Modelling, Turkey, Istanbul, September 05-10, 2004; CADD & D Society in Turkey: Istanbul, 2004; p. 63.
21. Furlanetto, M.; Santos, M.G.B.; Tavares, L.C. Abstracts of Papers. VI Semana Farmacêutica de Ciência e Tecnologia da FCF-USP, São Paulo, Oct 15-19, 2001; RBCF/Braz. J. Pharm. Sci., São Paulo, 2001; Suppl. 1, p. 62.
22. Jones M.E., Boenink N.M., Verhoef J., Kohrer K., and Schimitz F.J.J. Antimicrob. Chemother. 45 (2000) 353
23. In: Collins C.H., Lyne P.M., and Grange J.M. (Eds). Collins and Lyne's Microbiological Methods. 7th ed. (1995), Butterworth-Heinemann, Oxford 179-215
24. Bauer A.W., Kirby W.M.M., Sherris J.C., and Truck M. Am. J. Clin. Pathol. 36 (1966) 493